{
  "abstract": "Background and Importance The neonatal intensive care unit (NICU) is a high-risk environment where medication management requires precision, evidence-based protocols and interdisciplinary collaboration. The integration of clinical pharmacists into the NICU team has been shown to optimise pharmacotherapy and improve therapeutic outcomes, however, their administrative impact is under studied.Aim and Objectives This study aimed to measure the administrative impact of specialist clinical pharmacist using defined key performance indicators (KPIs) that reflect contribution beyond direct patient care.Material and Methods This study took place at Sultan Qaboos University hospital (SQUH), a tertiary care teaching institution, with a 24-bed NICU. A retrospective review of pharmacist led initiatives over a period of 18 months (Jan 2024 - Jun 2025) was conducted using targeted KPIs. These KPIs were based on existing SQUH pharmacy practice standards and were adopted from international standards (eg, ASHP, ISMP). Data across five administrative domains including: formulary additions, guideline development, staff education, pharmacovigilance and Respiratory Syncytial Virus (RSV) prophylaxis planning were captured. Data were collected from pharmacy & therapeutics committee records and electronic patient records (EPR). Descriptive statistics (frequencies and percentages) were used to analyse KPI metrics.Results Five new key neonatal medications were added to formulary including: probiotics (Proprems sachets), 40% oral glucose gel, injection bumetanide, sirolimus solution and ready to mix standard total parenteral nutrition (TPN) solutions. Six neonatal clinical guidelines were developed during the study period; HIV prophylaxis, probiotics prescribing and administration, management of hypoglycaemia, inhaled steroids prescribing, fluconazole prophylaxis and TPN administration guide. Twenty ADRs were detected and documented on a designated form within the EPR, primarily involving caffeine (N=4, 20%), and fluconazole (N=2, 10%). The pharmacist coordinated RSV prophylaxis protected 152 at risk infants during the RSV seasons, and enabled accurate forecasting of palivizumab requirements for the next season with 10% estimation margins. A structured course on TPN was designed and delivered to nurses and dietitians, with pre- and post-course assessments showing an increase in knowledge scores in 88%, and improved confidence in TPN management in 96% of the participants (N=57).Conclusion and Relevance The use of targeted KPIs provides objective evidence of the administrative impact of a specialist clinical pharmacist in the NICU.References and/or Acknowledgements 1. https://doi.org/10.1136/ejhpharm-2017-0014322. https://doi.org/10.18549/PharmPract.2022.3.2708Conflict of Interest No conflict of interest",
  "authors": [
    {
      "affiliations": [
        "Sultan Qaboos University Hospital, Pharmacy, Muscat, Oman"
      ],
      "name": "A Taqi"
    }
  ],
  "title": "4CPS-317 Measuring the administrative impact of a specialist clinical pharmacist at a neonatal intensive care unit of a teaching hospital in Oman using key performance indicators",
  "uid": "ef5a830c-2c30-519b-acfe-7bb2d10ef3e7"
}